MTVA
MetaVia Inc.
NASDAQ: MTVA · HEALTHCARE · BIOTECHNOLOGY
$1.44
-3.36% today
Updated 2026-04-30
Market cap
$8.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-7.35
Dividend yield
—
52W range
$1 – $19
Volume
0.1M
MetaVia Inc. (MTVA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-195000.00 | $-5.43M | $-11.04M | $-26.90M | $-14.45M | $-7.04M | $-10.76M | $-15.13M | $-11.71M | $-10.80M | $-24.71M | $-15.70M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $3000.00 | $214000.00 | $4000.00 | $3000.00 | $0.00 | $50000.00 | $8000.00 | $2000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $53000.00 | $284000.00 | $1.72M | $5.27M | — | $118000.00 | $699000.00 | $662000.00 | $854000.00 | $222000.00 | $538000.00 | $411000.00 |
| Free cash flow | $-195000.00 | $-5.43M | $-11.04M | $-26.90M | $-14.45M | $-7.25M | $-10.77M | $-15.14M | $-11.71M | $-10.85M | $-24.72M | $-15.70M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |